Who is sponsoring NCT04566068?

NCT04566068 is sponsored by Massachusetts General Hospital.

What drugs are being tested in NCT04566068?

Interventions in NCT04566068: Intervention- Adapted Virtual Insomnia Program, Control- Enhanced usual care.

What condition does NCT04566068 study?

NCT04566068 studies Cancer, Insomnia.

Is NCT04566068 still recruiting?

NCT04566068 is currently completed. Last updated 11 April 2022.

Last reviewed 2022-04-11 · How we verify

NCT04566068

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Survivorship Sleep Program

Completed NA Last updated 11 April 2022

What this trial tests

NA trial testing Intervention- Adapted Virtual Insomnia Program in Cancer in 40 participants. Completed in 16 June 2021.

Timeline

1 October 2020

Primary endpoint
16 June 2021

16 June 2021

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	1 October 2020
Primary completion	16 June 2021
Estimated completion	16 June 2021
Sites	1 location across United States

Drugs / interventions tested

Intervention- Adapted Virtual Insomnia Program
Control- Enhanced usual care

Conditions studied

Cancer — all drugs for Cancer →
Insomnia — all drugs for Insomnia →

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Cancer or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized pilot trial to test the feasibility and acceptability (primary outcomes) of a virtual cognitive behavioral program for insomnia for survivors of various cancer types. Secondary outcomes are to examine the preliminary effects on reducing insomnia severity from baseline to post-intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors.
Hall DL, Arditte Hall KA, Gorman MJ, Comander A, et al · · 2022 · cited 13× · PMID 34914845 · DOI 10.1002/cncr.34066
Treatment-related changes in insomnia, anticipatory pleasure, and depression symptoms: A proof-of-concept study with cancer survivors.
Wieman ST, Arditte Hall KA, Park ER, Gorman MJ, et al · · 2023 · cited 3× · PMID 36739822 · DOI 10.1016/j.sleep.2023.01.011
An exploration into the relationship between insomnia and repetitive negative thinking among cancer survivors.
Arditte Hall KA, Price SN, Lucas AR, Park ER, et al · · 2025 · cited 2× · PMID 38831557 · DOI 10.1080/07347332.2024.2356193

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Massachusetts General Hospital trials

Trials by the same sponsor.

NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04566068 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04566068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing